• The Economics of Ozempic & Other Weight Loss Drugs: A Deep Dive with Ben Ippolito

  • May 20 2024
  • Length: 46 mins
  • Podcast

The Economics of Ozempic & Other Weight Loss Drugs: A Deep Dive with Ben Ippolito By cover art

The Economics of Ozempic & Other Weight Loss Drugs: A Deep Dive with Ben Ippolito

Listen for free

View show details

  • Summary

  • Join hosts Joe Grogan and Eric Ueland on DC EKG as they delve into the complexities of health economics in America with special guest Ben Ippolito. In this episode, they explore the skyrocketing prices of GLP-1 weight loss drugs and discuss the potential for Medicare coverage. Ben Ippolito sheds light on the current prohibition against Medicare covering weight loss drugs, the shift from viewing obesity as a cosmetic issue to recognizing it as a clinical outcome, and the high out-of-pocket expenses people are willing to pay. Ben also examines the business implications for pharmaceutical companies if Medicare covers these drugs, the impact of price caps under the IRA, and the competitive challenges new market entrants face. --LINKS-- Follow DC EKG: https://twitter.com/DCEKGpodcast Follow Ben: https://twitter.com/ben_ippolito
    Show more Show less
activate_primeday_promo_in_buybox_DT
Hygiene & Healthy Living Political Science
Show more Show less

What listeners say about The Economics of Ozempic & Other Weight Loss Drugs: A Deep Dive with Ben Ippolito

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available